K, v. R., & JA, L. (2013). A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation. Dove Medical Press.
Cita Chicago Style (17a ed.)K, van Rossem, y Lowe JA. A Phase 1, Randomized, Open-label Crossover Study to Evaluate the Safety and Pharmacokinetics of 400 Mg Albaconazole Administered to Healthy Participants as a Tablet Formulation Versus a Capsule Formulation. Dove Medical Press, 2013.
Cita MLA (8a ed.)K, van Rossem, y Lowe JA. A Phase 1, Randomized, Open-label Crossover Study to Evaluate the Safety and Pharmacokinetics of 400 Mg Albaconazole Administered to Healthy Participants as a Tablet Formulation Versus a Capsule Formulation. Dove Medical Press, 2013.